ReviewToxicology mechanisms and methods2013
Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation.
Review in Toxicology mechanisms and methods, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Can the biomolecular corona induce an allergic reaction?-A proof-of-concept study.Biointerphases · 2021Trial
- Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies.Viruses · 2023Review
- Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects.Nanomaterials (Basel, Switzerland) · 2022Review
- A Systematic Review of Biosynthesized Metallic Nanoparticles as a Promising Anti-Cancer-Strategy.Cancers · 2021Review
- Toxicology data of graphene-family nanomaterials: an update.Archives of toxicology · 2020Review
- Engineered nanomaterials and oxidative stress: current understanding and future challenges.Current opinion in toxicology · 2019Article
- Article
- Contribution of engineered nanomaterials physicochemical properties to mast cell degranulation.Scientific reports · 2017Article
- Protein bio-corona: critical issue in immune nanotoxicology.Archives of toxicology · 2017Review
- Immunotoxicological impact of occupational and environmental nanoparticles exposure: The influence of physical, chemical, and combined characteristics of the particles.International journal of immunopathology and pharmacology · 2016Review
- Article
- Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Chemical Society reviews · 2016Review
- Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.International journal of nanomedicine · 2015Review
- Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis.International journal of nanomedicine · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Abstract Engineered nanomaterials (ENMs) are increasingly being utilized in many consumer products and various medical applications, thereby leading to the potentiality of increased human exposures. Assessment of the adverse effects on the immune system is an important component for evaluating the overall health and safety of ENM. Tasked with eliminating pathogens and removing cancerous cells, the immune system is constantly functioning to maintain homeostasis. Small modifications to the immune system, which may occur following ENM exposure, could lead to impaired protection or an inappropriate immune response resulting in autoimmunity and damage to the host. This review seeks to survey and evaluate the current literature to better understand the impact of ENM exposure on cells critical to the innate and adaptive immune systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.